Screening for unknown mutations by a bioluminescent protein truncation test with homogeneous detection.

Autor: Petrakis EC; Department of Chemistry, University of Patras, Patras, Greece 26500., Trantakis IA, Kalogianni DP, Christopoulos TK
Jazyk: angličtina
Zdroj: Journal of the American Chemical Society [J Am Chem Soc] 2010 Apr 14; Vol. 132 (14), pp. 5091-5.
DOI: 10.1021/ja909200p
Abstrakt: The protein truncation test (PTT) is important in screening for unknown mutations that cause premature termination of mRNA translation. PTT involves amplification of the interrogated sequence, in vitro transcription/translation, separation of the generated polypeptides, and detection. In this article, we report a bioluminescent protein truncation test, in which the detection of the nascent protein is performed directly in the expression mixture, within seconds, without the need for separation and purification. A DNA fragment encoding apoaequorin is fused, in-frame, downstream of the interrogated sequence. The fusion product is subjected to in vitro, coupled transcription and translation in the presence of coelenterazine. A wild-type DNA template allows translation to continue after the 3' end of the interrogated sequence, producing a chimeric protein whose C-terminal domain is the photoprotein aequorin. Aequorin is detected, with a high sensitivity, by its characteristic Ca(2+)-triggered, flash-type bioluminescent reaction. Active photoprotein is not produced when a truncating mutation is present in the interrogated sequence. As a model, the method was applied to the detection of truncating mutations in the APC gene (adenomatous polyposis coli).
Databáze: MEDLINE